Sign up
Pharma Capital

eWellness Healthcare targeting $7 billion injury-prevention industry via sales, marketing

From 2013 to 2018, Occupational Health and Workplace Safety Services industry revenue increased at an annualized rate of 2.3%
health
The California-based company, which has operations in the US and Canada, offers the PHZIO telemedicine platform

eWellness Healthcare Corporation (OTCQB:EWLL), the physical therapy telehealth company, announced Friday that it is targeting the $7 billion injury-prevention industry through sales and marketing.

The company noted that, according to business-information provider IBISWorld, the Occupational Health and Workplace Safety Services industry in the US provides advice and assistance in the form of worksite evaluations, compliance audits, hazard assessments, facility-design reviews, indoor air-quality evaluations and training programs.

From 2013 and 2018, industry revenue increased at an annualized rate of 2.3% to $7.1 billion.

Following Friday’s announcement, the company’s stock jumped 31% to $0.07 on the OTC Markets.

READ: eWellness Healthcare doubles down on $4 billion North American musculoskeletal treatment market

The Culver City, California-based company, which has operations in the US and Canada, offers the PHZIO telemedicine platform.

eWellness says its PHZIO platform allows patients and physical therapists to “cut the cord from the old-school, wait in line, brick and mortar clinical experience” to an “immediate response,” digital in-home physical therapy experience.

The company offers insurance-reimbursable, real-time, distance-monitored treatments.

The company’s PHZIO platform lowers treatment costs, expands treatment access and improves patient compliance.

eWellness says that at least 80% of all physical therapy assessments and treatments can now be done via a patient’s smartphone.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

1556543955_patrick.graham.jpg
Why Invest In eWellness Healthcare Corp.? Read More Here

Register here to be notified of future EWLL Company articles
View full EWLL profile View Profile
View All

Related Articles

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.